Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Sol-Gel Technologies Ltd (SLGL)

Sol-Gel Technologies Ltd (SLGL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 128,967
  • Shares Outstanding, K 20,390
  • Annual Sales, $ 31,270 K
  • Annual Income, $ 3,220 K
  • 60-Month Beta 1.11
  • Price/Sales 4.78
  • Price/Cash Flow 32.07
  • Price/Book 2.37
Trade SLGL with:

Options Overview Details

View History
  • Implied Volatility 60.78% ( -47.75%)
  • Historical Volatility 58.98%
  • IV Percentile 4%
  • IV Rank 26.65%
  • IV High 216.95% on 12/27/21
  • IV Low 4.03% on 01/19/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 6
  • Put/Call OI Ratio 0.05
  • Today's Open Interest 3,169
  • Open Int (30-Day) 3,149

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.17
  • Number of Estimates 2
  • High Estimate -0.15
  • Low Estimate -0.19
  • Prior Year -0.35
  • Growth Rate Est. (year over year) +51.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.50 +12.64%
on 05/11/22
7.40 -16.28%
on 04/25/22
-0.96 (-13.48%)
since 04/20/22
3-Month
5.50 +12.64%
on 05/11/22
7.95 -22.08%
on 03/30/22
-1.17 (-15.94%)
since 02/18/22
52-Week
5.50 +12.64%
on 05/11/22
14.50 -57.28%
on 07/27/21
-4.04 (-39.50%)
since 05/20/21

Most Recent Stories

More News
SolGel Technologies Ltd. (SLGL) Reports Q1 Loss, Misses Revenue Estimates

SolGel Technologies Ltd. (SLGL) delivered earnings and revenue surprises of 20% and 99.85%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

SLGL : 6.20 (-2.06%)
FIXX : 1.5500 (-6.06%)
Sol-Gel Technologies Reports First Quarter 2022 Financial Results and Provides Corporate Update

FDA approval for EPSOLAY® (benzoyl peroxide, cream, 5%) represents Sol-Gel’s second approved product within less than a year; EPSOLAY is patent protected...

SLGL : 6.20 (-2.06%)
Amphastar Pharmaceuticals (AMPH) Q1 Earnings and Revenues Top Estimates

Amphastar (AMPH) delivered earnings and revenue surprises of 42.42% and 8.83%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

AMPH : 33.70 (unch)
SLGL : 6.20 (-2.06%)
Generation Bio Co. (GBIO) Reports Q1 Loss, Lags Revenue Estimates

Generation Bio Co. (GBIO) delivered earnings and revenue surprises of -17.31% and 100%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

GBIO : 5.41 (+5.25%)
SLGL : 6.20 (-2.06%)
Earnings Preview: SolGel Technologies Ltd. (SLGL) Q1 Earnings Expected to Decline

SolGel Technologies Ltd. (SLGL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SLGL : 6.20 (-2.06%)
3 Generic Drug Stocks to Watch Amid Continued Pricing Pressure

The impact of COVID-19 and continued pricing pressure on the Zacks Medical-Generic Drugs industry remains. New product launches may provide some respite for BHC, AMPH and SLGL.

BHC : 9.93 (-2.17%)
AMPH : 33.70 (unch)
SLGL : 6.20 (-2.06%)
Sol-Gel Technologies and Galderma Announce FDA Approval of EPSOLAY®

EPSOLAY (benzoyl peroxide, cream, 5%) utilizes Sol-Gel’s proprietary microencapsulation technology for the treatment of inflammatory lesions of rosacea and...

SLGL : 6.20 (-2.06%)
Sol-Gel Technologies Announces the Commercial Availability of TWYNEO®

TWYNEO is the first-ever tretinoin and benzoyl peroxide combination to treat facial acneSol-Gel’s U.S. commercialization partner, Galderma, launched...

SLGL : 6.20 (-2.06%)
Sol-Gel Technologies Reports Full Year 2021 Financial Results and Corporate Developments

Galderma launched TWYNEO® at the Annual Meetings of the American Academy of Dermatology, March 25-29, 2022 in Boston, MA. TWYNEO will be commercially...

SLGL : 6.20 (-2.06%)
Sol-Gel Technologies Announces U.S. Commercial Partner Galderma to Promote TWYNEO® at the American Academy of Dermatology Annual Meeting to be Held March 25-29 in Boston, MA

TWYNEO will be officially launched for commercial availability in Spring 2022....

SLGL : 6.20 (-2.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Sol-Gel Technologies Ltd.is a clinical-stage dermatology company. It focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Its product candidates include VERED for the treatment of papulopustular rosacea, TWIN and SIRS-T for...

See More

Key Turning Points

3rd Resistance Point 6.39
2nd Resistance Point 6.35
1st Resistance Point 6.27
Last Price 6.20
1st Support Level 6.16
2nd Support Level 6.12
3rd Support Level 6.04

See More

52-Week High 14.50
Fibonacci 61.8% 11.06
Fibonacci 50% 10.00
Fibonacci 38.2% 8.94
Last Price 6.20
52-Week Low 5.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar